Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen, Chien-Yuan ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 74 | 69 | |
2022 | Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome | Wang, Yu-Hung; CHIEN-CHIN LIN ; CHI-YUAN YAO ; Hsu, Chia-Lang; CHENG-HONG TSAI ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | British journal of haematology | 2 | 2 | |
2019 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients | CHENG-HONG TSAI ; CHI-YUAN YAO ; FENG-MING TIEN ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chiu, Yu-Chiao; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | EBioMedicine | 21 | 22 | |
2018 | Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome | HSIN-AN HOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; LIANG-IN LIN ; MING YAO ; JIH-LUH TANG ; HWEI-FANG TIEN | Blood Cancer Journal | 62 | 59 | |
2014 | Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia | HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; JIH-LUH TANG ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia | 75 | 73 | |
2014 | IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients | YI-TSUNG YANG ; HSIN-AN HOU ; Liu C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG ; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Lin C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 19 | 16 | |
2012 | A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic Microenvironment | Chou S.-H.; BOR-SHENG KO ; Chiou J.-S.; Hsu Y.-C.; MONG-HSUN TSAI ; Chiu Y.-C.; Yu I.-S.; SHU-WHA LIN ; HSIN-AN HOU ; Kuo Y.-Y.; Lin H.-M.; Wu M.-F.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | PLoS ONE | 20 | 17 | |
2020 | Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice | CHIEN-CHIN LIN ; CHI-YUAN YAO ; Hsu, Yueh-Chwen; HSIN-AN HOU ; CHANG-TSU YUAN ; Li, Yi-Hung; Kao, Chein-Jun; Chuang, Po-Han; Chiu, Yu-Chiao; Chen, Yidong; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Oncogene | 14 | 12 | |
2023 | Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy | Wu, Jia-Rong; Shih, Pei-Chun; Li, Ching; Chao, Hsiao-Ling; Wang, Hsiao-Chun; Chiang, Yi-Mei; Liu, Yu-Jung; SZU-CHUN HSU ; CHI-YUAN YAO ; Chen, Lo-Ho; CHIEN-CHIN LIN ; HWEI-FANG TIEN ; WEN-CHIEN CHOU | JOURNAL OF HEMATOPATHOLOGY | 0 | 0 | |
2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
2007 | Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia | Lee C.-Y.; HWEI-FANG TIEN ; CHUNG-YI HU ; WEN-CHIEN CHOU ; LIANG-IN LIN | British Journal of Cancer | 44 | 35 | |
2008 | Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia | Lee C.-Y.; HWEI-FANG TIEN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN | British Journal of Haematology | 16 | 14 | |
2018 | Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information | Tefferi A.; Gangat N.; Mudireddy M.; Lasho T.L.; Finke C.; Begna K.H.; Elliott M.A.; Al-Kali A.; Litzow M.R.; Hook C.C.; Wolanskyj A.P.; Hogan W.J.; Patnaik M.M.; Pardanani A.; Zblewski D.L.; He R.; Viswanatha D.; Hanson C.A.; Ketterling R.P.; JIH-LUH TANG ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; HWEI-FANG TIEN ; HSIN-AN HOU | Mayo Clinic Proceedings | 18 | 19 | |
2015 | An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype | MING-KAI CHUANG ; Chiu Y.-C.; WEN-CHIEN CHOU ; HSIN-AN HOU ; Tseng M.-H.; Kuo Y.-Y.; Chen Y.; Chuang E.Y.; HWEI-FANG TIEN | Oncotarget | 38 | 40 | |
2012 | Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia | Kantarjian H.M.; Thomas X.G.; Dmoszynska A.; Wierzbowska A.; Mazur G.; Mayer J.; Gau J.-P.; WEN-CHIEN CHOU ; Buckstein R.; Cermak J.; Kuo C.-Y.; Oriol A.; Ravandi F.; Faderl S.; Delaunay J.; Lys?k D.; Minden M.; Arthur C. | Journal of Clinical Oncology | 942 | 857 | |
2014 | The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression | YUAN-YEH KUO ; HSIN-AN HOU ; YIN-KAI CHEN ; Li, Li-Yu; Chen, Po-Hsuen; Tseng, Mei-Hsuan; Huang, Chi-Fei; Lee, Fen-Yu; Liu, Ming-Chih; Liu, Chia-Wen; WEN-CHIEN CHOU ; Liu, Chieh-Yu; JIH-LUH TANG ; MING YAO ; HWEI-FANG TIEN | Haematologica | 10 | 10 | |
2006 | A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias [8] | LIANG-IN LIN ; Lin T.-C.; WEN-CHIEN CHOU ; JIH-LUH TANG ; Lin D.-T.; HWEI-FANG TIEN | Leukemia | 46 | 43 | |
2006 | Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution | WEN-CHIEN CHOU ; JIH-LUH TANG ; LIANG-IN LIN ; MING YAO ; WOEI TSAY ; Chen, Chien-Yuan ; SHANG-JU WU ; Huang C.-F.; Chiou R.-J.; Tseng M.-H.; Lin D.-T.; Lin K.-H.; YAO-CHANG CHEN ; HWEI-FANG TIEN | Cancer Research | 150 | 139 | |
2022 | Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair | Chen, Tsung-Chih; CHI-YUAN YAO ; Chen, Yu-Ren; CHANG-TSU YUAN ; CHIEN-CHIN LIN ; Hsu, Yueh-Chwen; Chuang, Po-Han; Kao, Chein-Jun; Li, Yi-Hung; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Oncogene | 2 | 2 | |
2022 | PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients | Lee, Sze-Hwei; CHIEN-CHIN LIN ; Wei, Chao-Hong; Chang, Ko-Ping; CHANG-TSU YUAN ; CHENG-HONG TSAI ; Liu, Jia-Hao; HSIN-AN HOU ; Tang, Jih-Lu; WEN-CHIEN CHOU ; HWEI-FANG TIEN | The journal of pathology. Clinical research | 1 | 1 | |